NVN Liquidation Inc (NOVNQ)
0.00
0.00 (0.00%)
USD |
OTCM |
Apr 30, 16:00
NVN Liquidation Net Income (TTM): -32.05M for March 31, 2023
Net Income (TTM) Chart
Historical Net Income (TTM) Data
| Date | Value |
|---|---|
| March 31, 2023 | -32.05M |
| December 31, 2022 | -31.31M |
| September 30, 2022 | -36.52M |
| June 30, 2022 | -36.98M |
| March 31, 2022 | -34.12M |
| December 31, 2021 | -29.69M |
| September 30, 2021 | -28.09M |
| June 30, 2021 | -30.02M |
| March 31, 2021 | -32.08M |
| December 31, 2020 | -29.29M |
| September 30, 2020 | -28.61M |
| June 30, 2020 | -29.70M |
| March 31, 2020 | -29.91M |
| December 31, 2019 | -30.38M |
| Date | Value |
|---|---|
| September 30, 2019 | -33.84M |
| June 30, 2019 | -31.38M |
| March 31, 2019 | -30.66M |
| December 31, 2018 | -29.24M |
| September 30, 2018 | -27.90M |
| June 30, 2018 | -28.19M |
| March 31, 2018 | -30.46M |
| December 31, 2017 | -36.62M |
| September 30, 2017 | -41.61M |
| June 30, 2017 | -51.76M |
| March 31, 2017 | -59.82M |
| December 31, 2016 | -59.70M |
| September 30, 2016 | -57.80M |
| June 30, 2016 | -46.41M |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (TTM) Range, Past 5 Years
-36.98M
Minimum
Jun 2022
-28.09M
Maximum
Sep 2021
-31.50M
Average
-30.84M
Median
Net Income (TTM) Benchmarks
| Cantabio Pharmaceuticals Inc | -1.543M |
| Q BioMed Inc | -0.4851M |
| Affymax Inc | -- |
| Scopus BioPharma Inc | -8.696M |
| Statera BioPharma Inc | -91.83M |